A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: theatrical (1), dramatic (4)

Hysterosalpingogram (HSG) - patient information

Description
This factsheet contains information about having a hysterosalpingogram (HSG).
Url
/Media/UHS-website-2019/Patientinformation/Scansandx-rays/Hysterosalpingogram-HSG-3095-PIL.pdf

General exercises after having a spinal cord stimulator implant - patient information

Description
This factsheet contains some exercises to do at home to help improve the range of movement in your body after having
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/General-exercises-after-having-a-spinal-cord-stimulator-implant-3022-PIL.pdf

Cisplatin-Etoposide (intravenous)

Description
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CISPLATIN-ETOPOSIDE (Intravenous) Regimen SCLC – Cisplatin-Etoposide IV Indication Limited stage SCLC Usually given
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-small-cellSCLC/Cisplatin-Etoposideintravenous.pdf

Osimertinib

Description
Chemotherapy Protocol Lung cancer - Non-small cell (NSCLC) OSIMERTINIB Regimen • NSCLC - Osimertinib Indication • Osimertinib is available as an option within the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Osimertinib.pdf

Alectinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ALECTINIB Regimen • NSCLC - ALECtinib Indication • Alectinib (as monotherapy) is indicated for first-line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Alectinib.pdf

Rituximab SC (8 weekly) Ver 1

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (8 weekly) Regimen Lymphoma – Rituximab SC (8 weekly) Indication Maintenance single agent therapy in previously untreated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-8-weekly-Ver-1.pdf

Rituximab SC (12 weekly) Ver1

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB SC (12 weekly) Regimen Lymphoma – Rituximab SC (12 weekly) Indication Maintenance single agent therapy in relapsed / refractory
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-SC-12-weekly-Ver1.pdf

Ponatinib

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Ponatinib All licensed indications are not funded therefore an application for funding is required before prescribing
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Ponatinib.pdf

Risk-reducing bilateral salpingo-oophorectomy (RRBSO) - patient information

Description
This factsheet explains what a risk-reducing bilateral salpingo-oophorectomy (RRBSO) is, what the procedure involves, and what the potential advantages
Url
/Media/UHS-website-2019/Patientinformation/Womenshealth/Risk-reducing-bilateral-salpingo-oophorectomy-RRBSO-3080-PIL.pdf

Anaesthesia for neurosurgery - patient information

Description
Most neurosurgical operations are carried out under general anaesthesia.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Anaesthesia-for-neurosurgery1934.pdf
251 to 260 of 368
Previous … 24 25 26 27 28 … Next